Endothelium in embryonic hematopoietic tissues generates hematopoietic stem/progenitor cells; however, it is unknown how its unique potential is specified. We show that transcription factor Scl/Tal1 is essential for both establishing the hematopoietic transcriptional program in hemogenic endothelium and preventing its misspecification to a cardiomyogenic fate. Scl(-/-) embryos activated a cardiac transcriptional program in yolk sac endothelium, leading to the emergence of CD31+Pdgfrα+ cardiogenic precursors that generated spontaneously beating cardiomyocytes. Ectopic cardiogenesis was also observed in Scl(-/-) hearts, where the disorganized endocardium precociously differentiated into cardiomyocytes. Induction of mosaic deletion of Scl in Scl(fl/fl)Rosa26Cre-ER(T2) embryos revealed a cell-intrinsic, temporal requirement for Scl to prevent cardiomyogenesis from endothelium. Scl(-/-) endothelium also upregulated the expression of Wnt antagonists, which promoted rapid cardiomyocyte differentiation of ectopic cardiogenic cells. These results reveal unexpected plasticity in embryonic endothelium such that loss of a single master regulator can induce ectopic cardiomyogenesis from endothelial cells.

Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium / Van Handel, B; Montel-Hagen, A; Sasidharan, R; Nakano, H; Ferrari, R; Boogerd, C J; Schredelseker, J; Wang, Y; Hunter, S; Org, T; Zhou, J; Li, X; Pellegrini, M; Chen, J N; Orkin, S H; Kurdistani, S K; Evans, S M; Nakano, A; Mikkola, H K. - In: CELL. - ISSN 0092-8674. - 150:3(2012), pp. 590-605. [10.1016/j.cell.2012.06.026]

Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium

Ferrari R;
2012-01-01

Abstract

Endothelium in embryonic hematopoietic tissues generates hematopoietic stem/progenitor cells; however, it is unknown how its unique potential is specified. We show that transcription factor Scl/Tal1 is essential for both establishing the hematopoietic transcriptional program in hemogenic endothelium and preventing its misspecification to a cardiomyogenic fate. Scl(-/-) embryos activated a cardiac transcriptional program in yolk sac endothelium, leading to the emergence of CD31+Pdgfrα+ cardiogenic precursors that generated spontaneously beating cardiomyocytes. Ectopic cardiogenesis was also observed in Scl(-/-) hearts, where the disorganized endocardium precociously differentiated into cardiomyocytes. Induction of mosaic deletion of Scl in Scl(fl/fl)Rosa26Cre-ER(T2) embryos revealed a cell-intrinsic, temporal requirement for Scl to prevent cardiomyogenesis from endothelium. Scl(-/-) endothelium also upregulated the expression of Wnt antagonists, which promoted rapid cardiomyocyte differentiation of ectopic cardiogenic cells. These results reveal unexpected plasticity in embryonic endothelium such that loss of a single master regulator can induce ectopic cardiomyogenesis from endothelial cells.
2012
Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium / Van Handel, B; Montel-Hagen, A; Sasidharan, R; Nakano, H; Ferrari, R; Boogerd, C J; Schredelseker, J; Wang, Y; Hunter, S; Org, T; Zhou, J; Li, X; Pellegrini, M; Chen, J N; Orkin, S H; Kurdistani, S K; Evans, S M; Nakano, A; Mikkola, H K. - In: CELL. - ISSN 0092-8674. - 150:3(2012), pp. 590-605. [10.1016/j.cell.2012.06.026]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2874930
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 128
  • ???jsp.display-item.citation.isi??? 124
social impact